Associate Medical Director – Early-Phase Trials

IQVIA; Adelaide; Sur place; AUD 180 000 - 280 000; Plein temps

Résumé du poste

IQVIA is seeking an Associate Medical Director to lead medical and scientific aspects of early-phase development in ANZ and APAC. You will oversee clinical trial lifecycles, provide strategic medical input, and collaborate with sponsors, investigators, and internal teams to ensure safety, scientific integrity, and successful study execution.

The role emphasizes risk-based medical guidance, protocol review, and support for business development, with opportunities to influence a diverse portfolio

Qualifications

• Medical degree from an accredited, internationally recognised medical school.
• Current medical licence or eligibility to practise medicine in a recognised jurisdiction.
• Board certification or equivalent specialty training preferred.
• Experience as a Medical Monitor, Associate Medical Director, Medical Advisor, Investigator, or similar role within the pharmaceutical, biotechnology, CRO, or clinical research industry.
• Strong understanding of GCP, ICH guidelines, and applicable clinical research regulations.
• Demonstrated knowledge of drug development and clinical trial conduct.
• Experience in early clinical development, FIH, healthy volunteer, and/or Phase I studies strongly preferred.
• Oncology experience highly advantageous.
• Strong clinical judgement and a pragmatic, risk-based approach to decision-making.
• Effective communicator able to translate complex scientific and medical concepts into practical guidance.
• Proven ability to build trusted relationships with sponsors, investigators, and internal stakeholders.
• Collaborative team player able to work across multidisciplinary and geographically dispersed teams.
• Comfortable in a fast-paced, evolving environment and able to work independently with accountability and sound judgement.
• Passionate about early phase drug development, continuous learning, and contributing to a positive team culture.

Responsabilités

• Serve as the primary Medical Advisor for assigned studies, providing medical oversight throughout the clinical trial lifecycle.
• Act as a scientific partner to sponsors, investigators, and study teams, delivering expert medical guidance and strategic input for early phase development programmes.
• Provide medical support on protocol interpretation, eligibility assessments, safety management, dose escalation decisions, and other protocol-related issues.
• Review and contribute to study protocols, informed consent forms, Investigator's Brochures, case report forms, clinical study reports, patient narratives, and other key study documents.
• Conduct ongoing medical monitoring, including review of adverse events, serious adverse events, emerging safety signals, and clinically significant findings.
• Support SRCs, Dose Escalation Committees, and other governance activities through presentation and interpretation of clinical and safety data.
• Work closely with Pharmacovigilance and project teams on safety evaluations, medical reviews, analysis of similar events, and participant safety activities.
• Deliver therapeutic area and protocol-specific training to project teams, investigators, and study personnel.
• Support protocol development and study design, particularly for FIH, healthy volunteer, and other early phase studies.
• Contribute medical and scientific expertise to feasibility assessments, proposal development, bid defences, and other business development activities.
• Participate in sponsor strategy discussions and provide scientifically sound solutions for complex development programmes.

Description du poste

IQVIA is seeking an Associate Medical Director to lead medical and scientific aspects of early-phase development in ANZ and APAC. You will oversee clinical trial lifecycles, provide strategic medical input, and collaborate with sponsors, investigators, and internal teams to ensure safety, scientific integrity, and successful study execution.

The role emphasizes risk-based medical guidance, protocol review, and support for business development, with opportunities to influence a diverse portfolio